เริ่มกันเลย
ABBVIE INC CEDEAR EACH 10 REPR 1 COMABBVIE INC CEDEAR EACH 10 REPR 1 COMABBVIE INC CEDEAR EACH 10 REPR 1 COM

ABBVIE INC CEDEAR EACH 10 REPR 1 COM

ไม่มีการซื้อขาย
ดูในซูเปอร์ชาร์ต
ภาพรวม การเงิน ข่าว การสนทนา เทคนิค
พันธบัตร

หุ้นกู้ ABBV

ด้านล่างคือรายการของหุ้นกู้ ABBVIE INC CEDEAR EACH 10 REPR 1 COM นักลงทุนมักเลือกใช้หุ้นกู้ของบริษัทเพื่อเพิ่มเสถียรภาพในช่วงเวลาที่ตลาดผันผวน ศึกษาราคา อัตราผลตอบแทน และสถิติอื่นๆ และค้นหาการลงทุนที่เชื่อถือได้
สัญลักษณ์
YTM %
ราคา %
ดอกเบี้ย %
วันครบกำหนดอายุ
ยอดคงค้าง
มูลค่าหน้าตั๋ว
จำนวนเงินขั้นต่ำ
ผู้ออก
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6.72%76.50%4.63%2042-10-0167.493 M USD1,000.00 USD2,000.00 USDActavis, Inc.
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
6.21%81.69%4.75%2045-03-1553.51 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
5.98%86.00%4.85%2044-06-1565.232 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5.79%89.99%4.55%2035-03-15107.646 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5.21%90.84%3.20%2029-11-2162.515 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5.08%108.18%5.50%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
4.95%107.70%5.40%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
4.91%99.26%4.85%2044-06-151.008 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AA5QDALLERGAN FNDG 15/25
4.90%98.93%3.80%2025-03-15130.225 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
US287YAW9ABBVIE 16/46
4.89%93.77%4.45%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABBABBVIE 15/45
4.88%97.52%4.70%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
4.87%106.29%5.35%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
4.86%100.20%4.88%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
4.85%90.60%4.25%2049-11-215.745 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
4.80%94.91%4.40%2042-11-062.599 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
4.79%99.50%4.75%2045-03-15827.091 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
4.77%98.15%4.63%2042-10-01389.217 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
4.67%93.07%4.05%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
4.63%96.53%2.95%2026-11-219.245 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
4.52%97.98%4.30%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4.47%100.72%4.55%2035-03-151.681 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
4.44%100.48%4.50%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4.41%105.02%5.05%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4.30%99.32%3.60%2025-05-143.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4.21%99.60%3.80%2025-03-152.889 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4.20%104.27%4.95%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4.07%95.92%3.20%2029-11-215.437 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4.01%103.26%4.80%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4.00%98.73%3.20%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
3.96%97.90%2.95%2026-11-213.991 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XXS162262122ALLERGAN FNDG 17/29
3.92%92.27%2.13%2029-06-0136.462 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
3.91%102.11%4.80%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
3.90%101.36%4.25%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
3.64%96.09%2.63%2028-11-1572.107 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3.08%121.31%4.25%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3.04%126.76%4.75%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5066461AbbVie Inc. 2.6% 21-NOV-2024
3.00%99.61%2.60%2024-11-213.739 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2.97%128.71%4.85%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABGABBVIE 19/31
2.93%89.10%1.25%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2.82%99.23%2.63%2028-11-15427.793 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2.80%97.01%2.13%2029-06-01506.088 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS152090781ABBVIE 16/28
2.80%97.35%2.13%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2.68%94.14%0.75%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2.04%123.74%4.55%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
1.63%102.15%3.80%2025-03-151.268 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911714AbbVie Inc. 2.6% 21-NOV-2024
−3.63%106.34%2.60%2024-11-2110.86 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
——4.40%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
——3.80%2025-03-15—1,000.00 USD2,000.00 USDAbbVie, Inc.